Linked Life Data

9817078

Source:http://linkedlifedata.com/resource/pubmed/id/9817078

Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9817078rdf:typepubmed:Citationlld:pubmed
pubmed-article:9817078lifeskim:mentionsumls-concept:C0003818lld:lifeskim
pubmed-article:9817078lifeskim:mentionsumls-concept:C0237401lld:lifeskim
pubmed-article:9817078lifeskim:mentionsumls-concept:C0025885lld:lifeskim
pubmed-article:9817078lifeskim:mentionsumls-concept:C0221102lld:lifeskim
pubmed-article:9817078lifeskim:mentionsumls-concept:C0005437lld:lifeskim
pubmed-article:9817078lifeskim:mentionsumls-concept:C0332157lld:lifeskim
pubmed-article:9817078lifeskim:mentionsumls-concept:C1515926lld:lifeskim
pubmed-article:9817078pubmed:issue2lld:pubmed
pubmed-article:9817078pubmed:dateCreated1998-11-25lld:pubmed
pubmed-article:9817078pubmed:abstractTextWe have studied hepatic function in individuals chronically exposed to arsenic (As) via drinking water in Region Lagunera, Mexico. We studied 51 individuals living in three villages exposed to As in water. Nazareno (0.014 mgAs/l), Santa Ana (0.1 mgAs/l) and Benito Juárez (0.3 mgAs/l). We determined the serum activity of aspartate aminotransferase (SAT) and alanine aminotransferase (ALT) as indicators of hepatocellular injury and that of gamma-glutamyl-transpeptidase (GGT) and alkaline phosphatase (ALP) as indicators of cholestasic injury. Serum bilirubin was used as an indicator of organic conjugated anion transport. Total proteins, albumin and globulin fraction in serum were used as indicators of biosynthetic liver capacity. The main findings of this study were the predominantly conjugated hyperbilirubinemia and increased serum ALP activity which were related to the concentration of total arsenic (TAs) in urine, suggesting the presence of cholestasis in As-exposed individuals. No significant changes were observed in the other parameters studied.lld:pubmed
pubmed-article:9817078pubmed:languageenglld:pubmed
pubmed-article:9817078pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9817078pubmed:citationSubsetIMlld:pubmed
pubmed-article:9817078pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9817078pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9817078pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9817078pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9817078pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9817078pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9817078pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9817078pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9817078pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9817078pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9817078pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9817078pubmed:statusMEDLINElld:pubmed
pubmed-article:9817078pubmed:monthOctlld:pubmed
pubmed-article:9817078pubmed:issn0378-4274lld:pubmed
pubmed-article:9817078pubmed:authorpubmed-author:CebriánM EMElld:pubmed
pubmed-article:9817078pubmed:authorpubmed-author:AguilarCClld:pubmed
pubmed-article:9817078pubmed:authorpubmed-author:García-Vargas...lld:pubmed
pubmed-article:9817078pubmed:authorpubmed-author:Del RazoL MLMlld:pubmed
pubmed-article:9817078pubmed:authorpubmed-author:Hernández-Zav...lld:pubmed
pubmed-article:9817078pubmed:authorpubmed-author:BorjaV HVHlld:pubmed
pubmed-article:9817078pubmed:issnTypePrintlld:pubmed
pubmed-article:9817078pubmed:day15lld:pubmed
pubmed-article:9817078pubmed:volume99lld:pubmed
pubmed-article:9817078pubmed:ownerNLMlld:pubmed
pubmed-article:9817078pubmed:authorsCompleteYlld:pubmed
pubmed-article:9817078pubmed:pagination79-84lld:pubmed
pubmed-article:9817078pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:9817078pubmed:meshHeadingpubmed-meshheading:9817078-...lld:pubmed
pubmed-article:9817078pubmed:meshHeadingpubmed-meshheading:9817078-...lld:pubmed
pubmed-article:9817078pubmed:meshHeadingpubmed-meshheading:9817078-...lld:pubmed
pubmed-article:9817078pubmed:meshHeadingpubmed-meshheading:9817078-...lld:pubmed
pubmed-article:9817078pubmed:meshHeadingpubmed-meshheading:9817078-...lld:pubmed
pubmed-article:9817078pubmed:meshHeadingpubmed-meshheading:9817078-...lld:pubmed
pubmed-article:9817078pubmed:meshHeadingpubmed-meshheading:9817078-...lld:pubmed
pubmed-article:9817078pubmed:meshHeadingpubmed-meshheading:9817078-...lld:pubmed
pubmed-article:9817078pubmed:meshHeadingpubmed-meshheading:9817078-...lld:pubmed
pubmed-article:9817078pubmed:meshHeadingpubmed-meshheading:9817078-...lld:pubmed
pubmed-article:9817078pubmed:meshHeadingpubmed-meshheading:9817078-...lld:pubmed
pubmed-article:9817078pubmed:meshHeadingpubmed-meshheading:9817078-...lld:pubmed
pubmed-article:9817078pubmed:meshHeadingpubmed-meshheading:9817078-...lld:pubmed
pubmed-article:9817078pubmed:meshHeadingpubmed-meshheading:9817078-...lld:pubmed
pubmed-article:9817078pubmed:meshHeadingpubmed-meshheading:9817078-...lld:pubmed
pubmed-article:9817078pubmed:meshHeadingpubmed-meshheading:9817078-...lld:pubmed
pubmed-article:9817078pubmed:meshHeadingpubmed-meshheading:9817078-...lld:pubmed
pubmed-article:9817078pubmed:meshHeadingpubmed-meshheading:9817078-...lld:pubmed
pubmed-article:9817078pubmed:meshHeadingpubmed-meshheading:9817078-...lld:pubmed
pubmed-article:9817078pubmed:meshHeadingpubmed-meshheading:9817078-...lld:pubmed
pubmed-article:9817078pubmed:meshHeadingpubmed-meshheading:9817078-...lld:pubmed
pubmed-article:9817078pubmed:year1998lld:pubmed
pubmed-article:9817078pubmed:articleTitleAlteration in bilirubin excretion in individuals chronically exposed to arsenic in Mexico.lld:pubmed
pubmed-article:9817078pubmed:affiliationDepartamento de Farmacología y Toxicología, CINVESTAV-IPN, México, DF, Mexico.lld:pubmed
pubmed-article:9817078pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:9817078pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed